Minimum Interval for Strattera (Atomoxetine) Dose Increases
You should wait a minimum of 3 days before increasing the dose of Strattera (atomoxetine). 111
Dosing Algorithm Based on Weight
For Children and Adolescents ≤70 kg:
- Start: 0.5 mg/kg/day total daily dose
- Wait minimum 3 days
- Increase to target: 1.2 mg/kg/day (can be given once daily in morning OR divided into morning and late afternoon/evening doses)
- Maximum dose: 1.4 mg/kg/day or 100 mg/day, whichever is less 111
For Children and Adolescents >70 kg and Adults:
- Start: 40 mg/day
- Wait minimum 3 days
- Increase to target: 80 mg/day (once daily OR divided dosing)
- If inadequate response after 2-4 additional weeks: May increase to maximum 100 mg/day 111
Critical Safety Consideration: Why Not Faster?
Rapid dose escalation significantly increases gastrointestinal side effects. The FDA labeling explicitly warns that "initial somnolence and gastrointestinal tract symptoms" occur "particularly if the dosage is increased too rapidly" 2. The most common adverse effects—nausea, vomiting, abdominal pain, and somnolence—are dose-dependent and timing-dependent 33.
Special Populations Requiring Slower Titration
CYP2D6 Poor Metabolizers or Patients on Strong CYP2D6 Inhibitors:
These patients achieve significantly higher plasma levels and require a modified approach:
- Children/adolescents ≤70 kg: Start at 0.5 mg/kg/day, increase to 1.2 mg/kg/day only if symptoms fail to improve after 4 weeks and initial dose is well tolerated 11
- Children/adolescents >70 kg and adults: Start at 40 mg/day, increase to 80 mg/day only after 4 weeks if needed and tolerated 11
Strong CYP2D6 inhibitors include paroxetine, fluoxetine, and quinidine. Approximately 7% of the population are poor metabolizers with significantly higher plasma levels and longer half-lives 33.
Clinical Monitoring During Titration
Monitor closely during the first few months of treatment and at times of dose changes for:
- Suicidal ideation (FDA black box warning in children/adolescents) 333
- Cardiovascular parameters (heart rate and blood pressure increases) 2
- Gastrointestinal symptoms
- Appetite suppression and weight changes
Common Pitfall to Avoid
Do not rush to maximum doses. No additional benefit has been demonstrated for doses higher than 1.2 mg/kg/day in children and adolescents ≤70 kg 11. The 3-day minimum interval exists to allow assessment of tolerability before escalating further, reducing the risk of treatment-limiting side effects that could lead to discontinuation.